24.4 C
New York
Friday, June 12, 2026

Tag: pathogens

newssourceFORcompanyinformationcontent1marketreleases

Weekly Recap: 11 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including advances in sleep apnea treatments, fall detection for seniors...

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, announced today the appointment of Dieter Weinand as Chair of the Board of Directors, effective June 12, 2025. Mr. Weinand is the former Chief Executive Officer of Bayer Pharma AG with more than 25 years of experience as a senior business leader in the pharmaceutical industry. He takes over from Dr. Jeanne Bolger, who served as Chair since 2022 and will remain on the Board as a non-executive independent director.

ProGro BIO to Pursue EPA Approval for Organic Biocontrol Product Targeting Plant Fungal Pathogens, Nematodes and Foliar Insects

ATLANTA, June 11, 2025 /PRNewswire/ -- ProGro BIO, a leader in microbial-based agricultural solutions, has announced plans to seek U.S. Environmental Protection Agency (EPA)...

PESG Research Update: PolyPid SHIELD’s II Delivers Transformative Phase 3 Topline Results – Paradigm Shift in Surgical Infection Prevention

PESG issues a new briefing following PolyPid’s clinical success; Revolutionary 58% Reduction in Surgical Site Infections Positions PolyPid’s D-PLEX100 as Potential New Standard of Care in the Future 
PESG issues a new briefing following PolyPid’s clinical success; Revolutionary 58% Reduction in Surgical Site Infections Positions PolyPid’s D-PLEX100 as Potential New Standard of Care in the Future

They Took Her Baby: New Mercy For Animals Footage Reveals Heartbreaking Cruelty on New York Dairy Farm

Mercy For Animals releases new hidden-camera footage from a New York dairy farm tied to major brands, as bird flu and regulatory concerns escalate...

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers 
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers

A SAFE RAW MILK BREAKTHROUGH: TAMARACK BIOTICS EARNS FDA ACCEPTANCE OF INNOVATIVE TREATMENT

FRESNO, Calif., June 9, 2025 /PRNewswire/ -- In an historic milestone for food safety and nutrition, Tamarack Biotics secured U.S. FDA acceptance for its...

Wild About Sprouts® Celebrates World Food Safety Day with Breakthrough Cold-Grown® Technology That Redefines Safety and Nutrition

SCOTTSDALE, Ariz., June 6, 2025 /PRNewswire/ -- In honor of World Food Safety Day June 7, Wild About Sprouts® is shining a spotlight on...

Biodefense Market worth $1.81 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPathogens

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers